Partners In Practice Articles

Roswell Park Advances Its Mission

The National Cancer Institute (NCI) has affirmed its support for Roswell Park Comprehensive Cancer Center, renewing its status as one of 50 elite Comprehensive Cancer Centers and awarding a $22.5 million Cancer Center Support Grant to fund core research and education programs — the largest such a

Introducing Roswell Park Care Network

Roswell Park Comprehensive Cancer Center joined with hospitals, health systems, physicians and supportive care teams from across the state, all committed to reducing the burden of cancer, to launch the Roswell Park Care Network.

New Location in Orchard Park

Beginning in August 2019, the Roswell Park Care Network Southtowns medical oncology/hematology practice will move to 3041 Orchard Park Road in Orchard Park.

Survivorship Program Broadens Services

There are 128,000 cancer survivors in Western New York and many of these individuals must continue their surveillance after they have received a clean bill of health.

Improving Care Delivery Through Technology

Roswell Park Comprehensive Cancer Center is growing, and with that growth we’ve had to make many internal changes to meet the expectations of your patients. We’ve added services, crucial support staff and expertise in key areas.

Cytoreduction/HIPEC in Gastric Cancer: Who benefits, and when to consider it?

Gastric adenocarcinoma commonly spreads through carcinomatosis or peritoneal metastases (PM). This was often discovered at the time of attempted curative gastric resection, given the poor ability of preoperative staging CT scans to detect the presence and extent of PM. In patients where visible PMs are absent, diagnostic laparoscopy with peritoneal lavage and cytology has been shown to be an effective method of noting free intraperitoneal tumor cells. This is also defined as M1 disease and is generally associated with T3 or T4 primary gastric cancers.

Evolving Surgical Approaches to Treating Advanced Gastric Cancer

There has been significant debate over the use of minimally invasive resection for the management of advanced gastric cancer. Laparoscopic surgery appears as a favorable approach, given the previously reported decrease in postoperative pain, pulmonary complications, and hospital lengths of stay. The reluctance to widely adopt this technique centers on concerns about its oncologic completeness and the complexity of the procedure.